AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. Duopa is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube.It was appr...

Login to read story

Thursday, March 19, 2015

Show last days of articles

Folic Acid Lowers Stroke Risk for Those with High Blood Pres...

From NeurologyWire

The B vitamin known as folate may lower the odds of having a stroke, according to a large trial published in the Journal of the American Medical Assoc...Full story

Wednesday, March 18, 2015

Depression in Fathers Can Cause Anxiety in Toddlers

From NeurologyWire

A fathers depression during the first years of parenting as well as a mothers can put their toddler at risk of developing troubling behaviors such a...Full story

Monday, March 16, 2015

Brain Processes Ongoing Pain More Emotionally

From NeurologyWire

A look inside the brain: How differently do we perceive pain?A momentary lapse of concentration is all it takes for a finger to become trapped or spra...Full story

Friday, March 13, 2015

AAN Hosting Free Brain Health Event for Neurology Patients

From NeurologyWire

The American Academy of Neurology will host a brain health fair; a free, one-day event connecting hundreds of Washington, DC, area neurology patients,...Full story

Blood Pressure Drug Protects Against Symptoms of MS in Anima...

From NeurologyWire

An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal mo...Full story

Wednesday, March 11, 2015

Risk of Motor Vehicle Accidents is Higher in People With Sle...

From NeurologyWire

A new study finds that obstructive sleep apnea is associated with a significantly increased risk of motor vehicle accidents, and this risk is reduced ...Full story

Tuesday, March 10, 2015

How To Minimize The Impact Of Migraine On A Childs Life

From NeurologyWire

Migraine in children can have a major impact on their school performance, family and social lives. The American Migraine Foundation has released a set...Full story

Monday, March 09, 2015

Exposure to Endocrine Disruptors During Pregnancy Affects th...

From NeurologyWire

Prenatal exposure to low doses of the environmental contaminants polychlorinated biphenyls, or PCBs, change the developing brain in an area involved i...Full story

EMD Serono and Opexa Amend Agreement to Support Ongoing Deve...

From NeurologyWire

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement with Opex...Full story

Friday, March 06, 2015

Groups Commit Nearly $2M to Study Commonalities of Neurodege...

From NeurologyWire

Together, leading funders of research in the U.S., Canada and U.K. are advancing a global funding initiative aimed at better understanding the similar...Full story

Thursday, March 05, 2015

Cerebral Blood Flow as a Possible Marker for Concussion Outc...

From NeurologyWire

A new imaging study suggests that cerebral blood flow recovery in the brain could be a biomarker of outcomes in patients following concussion, accordi...Full story

One-third of Americans Do Not Have Access to Stroke Center W...

From NeurologyWire

One-third of the US population does not have access to a primary stroke center within one hour by ambulance, and even under optimal conditions, a larg...Full story

NIH-led Effort Launches Big Data Portal for Alzheimers Drug ...

From NeurologyWire

A National Institutes of Health-led public-private partnership has launched the new Alzheimers Big Data portal including delivery of the first wave o...Full story

Wednesday, March 04, 2015

FDA Requires Label Change for Testosterone Products

From NeurologyWire

FDA is requiring manufacturers of testosterone products make label changes about a possible increased risk of heart attacks and strokes in patients ta...Full story

Tuesday, March 03, 2015

FDA Agrees to Review Xadago (safinamide) as Add-on Therapy f...

From NeurologyWire

FDA has accepted the New Drug Application (NDA) for Xadago (safinamide), and will be reviewed as an add-on therapy for patients with early- to late-st...Full story